Proposed Data Collections Submitted for Public Comment and Recommendations, 19563-19564 [E9-9772]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
allowed for presentation by on-site
registrants may be less than for preregistered speakers and will be
determined by the number of persons
Preliminary Agenda Topics and
who register at the meeting.
Availability of Meeting Materials
Persons registering to make oral
comments are asked to do so through
Preliminary agenda topics include:
the online registration form (https://
• NICEATM–ICCVAM Update.
• Regulatory Acceptance of ICCVAM– ntp.niehs.nih.gov/go/7441) and to send
a copy of their statement to Dr. White
Recommended Alternative Test
(see ADDRESSES above) by June 17, 2009,
Methods.
• NRC Report Recognition and
to enable review by SACATM,
Alleviation of Pain in Laboratory
NICEATM–ICCVAM, and NIEHS/NTP
Animals.
staff prior to the meeting. Written
• Implementation of NICEATM–
statements can supplement and may
ICCVAM Five-Year Plan.
expand the oral presentation. If
• Federal Agency Research,
registering on-site and reading from
Development, Translation, and
written text, please bring 40 copies of
Validation Activities Relevant to the
the statement for distribution and to
NICEATM–ICCVAM Five-Year Plan
supplement the record.
(EPA and USDA).
Background Information on ICCVAM,
• Report on second meeting of
NICEATM, and SACATM
Independent Peer Review Panel:
ICCVAM is an interagency committee
Evaluation of the Updated Validation
composed of representatives from 15
Status of New Versions and
Federal regulatory and research agencies
Applications of the Murine Local
that use, generate, or disseminate
Lymph Node Assay: Assessing the
toxicological information. ICCVAM
Allergic Contact Dermatitis Potential of
conducts technical evaluations of new,
Chemicals and Products.
revised, and alternative methods with
• Report on the Independent
regulatory applicability and promotes
Scientific Peer Review Panel on
the development, scientific validation,
Alternative Ocular Safety Testing
regulatory acceptance, implementation,
Methods.
• Update from the Japanese Center for and national and international
harmonization of new, revised, and
the Validation of Alternative Methods.
alternative toxicological test methods
• Update from the European Centre
that more accurately assess the safety
for the Evaluation of Alternative
and hazards of chemicals and products
Methods.
and that refine, reduce, and replace
• Update from Health Canada.
A copy of the preliminary agenda,
animal use. The ICCVAM Authorization
committee roster, and additional
Act of 2000 [42 U.S.C. 285l–3]
information, when available, will be
established ICCVAM as a permanent
interagency committee of the NIEHS
posted on the NTP Web site (https://
under NICEATM. NICEATM
ntp.niehs.nih.gov/go/7441) or available
administers ICCVAM and provides
upon request (see ADDRESSES above).
scientific and operational support for
Following the SACATM meeting,
ICCVAM-related activities. NICEATM
summary minutes will be prepared and
and ICCVAM work collaboratively to
available on the NTP Web site or upon
evaluate new and improved test
request.
methods applicable to the needs of U.S.
Request for Comments
Federal agencies. Additional
Both written and oral public input on information about ICCVAM and
the agenda topics is invited. Written
NICEATM can be found on their Web
comments received in response to this
site (https://iccvam.niehs.nih.gov).
notice will be posted on the NTP Web
SACATM was established in response
site. Persons submitting written
to the ICCVAM Authorization Act
comments should include their name,
[Section 285l–3(d)] and is composed of
affiliation (if applicable), and
scientists from the public and private
sponsoring organization (if any) with
sectors. SACATM advises ICCVAM,
the document. Time is allotted during
NICEATM, and the Director of the
the meeting for presentation of oral
NIEHS and NTP regarding statutorily
comments and each organization is
mandated duties of ICCVAM and
allowed one time slot per public
activities of NICEATM. SACATM
comment period. At least 7 minutes will provides advice on priorities and
be allotted for each speaker, and if time
activities related to the development,
permits, may be extended up to 10
validation, scientific review, regulatory
minutes at the discretion of the chair.
acceptance, implementation, and
Registration for oral comments will also national and international
be available on-site, although time
harmonization of new, revised, and
pwalker on PROD1PC71 with NOTICES
Requests should be made at least 7 days
in advance of the meeting.
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
17:48 Apr 28, 2009
Jkt 217001
PO 00000
Frm 00079
Fmt 4703
Sfmt 4703
19563
alternative toxicological test methods.
Additional information about SACATM,
including the charter, roster, and
records of past meetings, can be found
at https://ntp.niehs.nih.gov/go/167.
Dated: April 22, 2009.
John R. Bucher,
Associate Director, National Toxicology
Program.
[FR Doc. E9–9845 Filed 4–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-09–0128]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 or send
comments to Maryam Daneshvar, CDC
Reports Clearance Officer, 1600 Clifton
Road, MS–D74, Atlanta, GA 30333 or
send an e-mail to omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Congenital Syphilis (CS) Case
Investigation and Report Form
(CDC73.126), OMB No. 0920–0128—
revision—National Center for HIV/
AIDS, Viral Hepatitis, Sexually
Transmitted Diseases, and Tuberculosis
Prevention, (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
E:\FR\FM\29APN1.SGM
29APN1
19564
Federal Register / Vol. 74, No. 81 / Wednesday, April 29, 2009 / Notices
Background and Brief Description
Reducing congenital syphilis is a
national objective in the DHHS Report
entitled ‘‘Healthy People 2010 (Vol. I
and II)’’. Objective 25–9 of the DHHS
document states the goal to ‘‘reduce
congenital syphilis to 1 new case per
100,000 live births’’. In order to meet
this national objective, an effective
surveillance system for congenital
Report’’ data collection form will be
removed because several states have
begun to use a 5-digit (rather than 4digit) FIPS code for city, and CDC data
systems cannot accommodate the new
codes.
The congenital syphilis data will
continue to be used to develop
intervention strategies and to evaluate
ongoing control efforts. There is no cost
to respondents other than their time.
syphilis must be continued to monitor
current levels of disease and progress
towards the year 2010 objective. The
purpose of the revision is to
accommodate minor change to the
‘‘Congenital Syphilis (CS) Case
Investigation and Report Form’’
(CDC73.126). In the proposed revision,
the ‘‘reporting city’’ and ‘‘resident city’’
information blocks in the ‘‘Congenital
Syphilis (CS) Case Investigation and
ESTIMATE OF ANNUALIZED BURDEN TABLE
No. of
responses per
respondent
No. of
respondents
Average
burden per
response
(in hours)
Total burden
(in hours)
Type of respondents
Name of form
State and local health departments ..
Congenital Syphilis (CS) Case Investigation and Report.
18
11
20/60
66
Total ...........................................
...........................................................
18
........................
........................
66
Dated: April 23, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E9–9772 Filed 4–28–09; 8:45 am]
BILLING CODE 4163–18–P
The Director, Management Analysis and
Services Office, has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities, for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 17, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9743 Filed 4–28–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Strengthening
National Capacity in Malaria and Other
Infectious Disease Operations
Research, Funding Opportunity
Announcement (FOA) CK09–003
pwalker on PROD1PC71 with NOTICES
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the aforementioned meeting.
Time And Date: 12 p.m.–3 p.m., June 11,
2009 (Closed).
Place: Teleconference.
Status: The meeting will be closed to the
public in accordance with provisions set
forth in Section 552b(c) (4) and (6), Title 5
U.S.C., and the Determination of the Director,
Management Analysis and Services Office,
CDC, pursuant to Public Law 92–463.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of ‘‘Strengthening National
Capacity in Malaria and Other Infectious
Disease Operations Research, Funding
Opportunity Announcement (FOA) CK09–
003.’’
Contact Person For More Information:
Wendy Carr, PhD, CDC, 1600 Clifton Road,
NE., Mailstop D60, Atlanta, GA 30333,
Telephone: (404) 498–2276.
VerDate Nov<24>2008
17:48 Apr 28, 2009
Jkt 217001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel.
Date: May 5, 2009.
PO 00000
Frm 00080
Fmt 4703
Sfmt 4703
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Telephone
Conference Call)
Contact Person: William C. Benzing, PhD,
Scientific Review Administrator, Scientific
Review Branch, Division Of Extramural
Research, NINDS/NIH/DHHS/Neuroscience
Center, 6001 Executive Boulevard, Suite
3204, MSC 9529, Bethesda, MD 20892, (301)
496–0660, benzingw@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: April 23, 2009.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. E9–9863 Filed 4–28–09; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
Notice is hereby given of a change in
the meeting of the National Institute of
Mental Health Special Emphasis Panel,
May 14, 2009, 9 a.m. to May 14, 2009,
5 p.m., Melrose Hotel, 2430
Pennsylvania Ave., NW., Washington,
DC 20037 which was published in the
Federal Register on April 17, 2009, 74
FR N17874.
The meeting will be held on June 2,
2009. The time and meeting location
E:\FR\FM\29APN1.SGM
29APN1
]]>Agencies
[Federal Register Volume 74, Number 81 (Wednesday, April 29, 2009)]
[Notices]
[Pages 19563-19564]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9772]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-09-0128]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960 or
send comments to Maryam Daneshvar, CDC Reports Clearance Officer, 1600
Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Congenital Syphilis (CS) Case Investigation and Report Form
(CDC73.126), OMB No. 0920-0128--revision--National Center for HIV/AIDS,
Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis
Prevention, (NCHHSTP), Centers for Disease Control and Prevention
(CDC).
[[Page 19564]]
Background and Brief Description
Reducing congenital syphilis is a national objective in the DHHS
Report entitled ``Healthy People 2010 (Vol. I and II)''. Objective 25-9
of the DHHS document states the goal to ``reduce congenital syphilis to
1 new case per 100,000 live births''. In order to meet this national
objective, an effective surveillance system for congenital syphilis
must be continued to monitor current levels of disease and progress
towards the year 2010 objective. The purpose of the revision is to
accommodate minor change to the ``Congenital Syphilis (CS) Case
Investigation and Report Form'' (CDC73.126). In the proposed revision,
the ``reporting city'' and ``resident city'' information blocks in the
``Congenital Syphilis (CS) Case Investigation and Report'' data
collection form will be removed because several states have begun to
use a 5-digit (rather than 4-digit) FIPS code for city, and CDC data
systems cannot accommodate the new codes.
The congenital syphilis data will continue to be used to develop
intervention strategies and to evaluate ongoing control efforts. There
is no cost to respondents other than their time.
Estimate of Annualized Burden Table
----------------------------------------------------------------------------------------------------------------
Average
No. of No. of burden per Total burden
Type of respondents Name of form respondents responses per response (in (in hours)
respondent hours)
----------------------------------------------------------------------------------------------------------------
State and local health Congenital 18 11 20/60 66
departments. Syphilis (CS)
Case
Investigation
and Report.
---------------------------------------------------------------------------------
Total..................... ................ 18 .............. .............. 66
----------------------------------------------------------------------------------------------------------------
Dated: April 23, 2009.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E9-9772 Filed 4-28-09; 8:45 am]
BILLING CODE 4163-18-P
